Page last updated: 2024-08-21

benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and oxotremorine

benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide has been researched along with oxotremorine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howard, MD; Karanth, S; Mirajkar, N; Pope, CN1

Other Studies

1 other study(ies) available for benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and oxotremorine

ArticleYear
Comparative effects of oral chlorpyrifos exposure on cholinesterase activity and muscarinic receptor binding in neonatal and adult rat heart.
    Toxicology, 2007, Sep-05, Volume: 238, Issue:2-3

    Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Chlorpyrifos; Cholinesterases; Female; Heart; Inhibitory Concentration 50; Male; Muscarinic Agonists; Myocardium; Oxotremorine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Tetraisopropylpyrophosphamide; Weight Gain; Weight Loss

2007